Skip to main content
Presentation
Long-Term Effect of Varenicline (Chantix®) in Four Ataxic Patients: Prolonged Symptomatic Benefit Following Drug Discontinuation
World Congress on Parkinson’s Disease and Related Disorders (2009)
  • Theresa A. Zesiewicz, University of South Florida
  • Kelly L. Sullivan
  • A. Miller
  • L. E. Dempsey
  • Israt Jahan, University of South Florida
  • L. Wecker
Abstract
This presentation was given at the World Congress on Parkinson’s Disease and Related Disorders.
Keywords
  • Long-term effect,
  • Varenicline,
  • Chantix,
  • Ataxic patients,
  • Prolonged symptomatic benefit,
  • Drug discontinuation
Disciplines
Publication Date
December 13, 2009
Location
Miami Beach, FL
Citation Information
Theresa A. Zesiewicz, Kelly L. Sullivan, A. Miller, L. E. Dempsey, et al.. "Long-Term Effect of Varenicline (Chantix®) in Four Ataxic Patients: Prolonged Symptomatic Benefit Following Drug Discontinuation" World Congress on Parkinson’s Disease and Related Disorders (2009)
Available at: http://works.bepress.com/kelly_sullivan/161/